Sunday, June 25, 2017 1:51:06 PM
At the top of the page there is a link to a presentation by the former CEO on some Cannabis podcast thingy from mid 2015. Looking through youtube, I found two older ones and I pulled out a few things:
Regarding the Lock Guard RTO, Hollister had this to say about the Lock Guard guys who kept shares in NMUS 'I've met almost all of them personally' and 'there are HUGE supporters of what we are doing'
That last comment did not age well.
Interestingly, Hollister claimed at this time they were agnostic towards synthetic or natural cannabinoids, saying the approval process and economics would determine the direction they go. This is obviously much different two years later, with Murphy taking a strict 'we don't touch the plant' tagline.
Like Vinpat had said, Hollister claimed NMUS was a 'US based GWPH' and the company was initially valued as such. Unfortunately for those who bought at those valuations, the market didn't agree and they got creamed. I'm glad I don't hear anyone from the company claiming this anymore; important to DO YOUR OWN THING in life.
At this point, they only had licensed the one patent (THC-VHS) but said the patent was broad and had 66 'sub-claims' for different uses. Also referenced a THC patch that was licensed from the U of Texas that I haven't heard anything about.
Hollister talks about Ingram joining the board 'great to have him because I don't have Any experience in Ophthalmology'...I couldn't believe he said something like that. Your a Boss of a pre-clinical biotech with a lead candidate in glaucoma and You Know Nothing about Ophthalmology. Yikes.
He also discusses that the sector has been against cannabis because while it may lower IOP, it also lowers blood pressure throughout the body, counteracting the positive effects. NB1111 delivery system takes care of this.
In both of these, they list MS and epilepsy as research candidates. Was their original plan to go after GW's indications, before realising this was not smart?
In general, I continue to Be super unimpressed Hollister. He was getting paid six figures to go on these webcasts and respond to questions from the audience that could be answered with a 5 minute google search:
'How much money will you need?'
'Why did you choose a rabbit model and will the effects be similar in humans?'
'Whats the difference between a bio tech and life sciences company?'
and Everytime he responds 'GREAT QUESTION THANK YOU SO MUCH FOR ASKING...'
Anyway, it is good to see that while the path has been a windy one, the thesis hasn't changed = glaucoma lead candidate, take advantage of UM IP, target designations with unmet medical needs that have research supporting cannabinoid efficacy.
Vinpat, when did CINV start to become something they were pursuing?
GLTFA DYODD
Recent SKYE News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2024 10:56:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/13/2024 09:18:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 10:12:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 09:25:07 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/09/2024 09:29:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:18:47 PM
- Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity • GlobeNewswire Inc. • 07/24/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 01:27:39 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/20/2024 04:15:09 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/17/2024 08:27:44 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:19:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:02:13 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM